Adenosine receptor agonists or antagonists alter antinociception, but did not show an interaction with imipramine-induced antinociception in the formalin test in mice

European Neuropsychopharmacology

Volumn 13, Issue 3, 2003, Pages 165-172

  Zarrindast, Mohammad Reza ^a   Matinrokh, Haleh ^a   Mojtahedzadeh Ardebili, Parastoo ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenosine drugs; Formalin test; Imipramine; Mouse

Indexed keywords

1,3 DIPROPYL 7 METHYLXANTHINE; 2 CHLOROADENOSINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; FORMALDEHYDE; IMIPRAMINE; PHENYLISOPROPYLADENOSINE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL;

EID: 0037406060     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00002-6     Document Type: Article

References (47)

1. Anderson G.M., Hall L.M., Horne W.C., Yang J.X. Adenosine dophosphate inhibits the serotonin transporter. Biochem. Biophys. Acta. 1283:1996;14-20.
2. Ansuategui M., Naharro L., Feria M. Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats. Psychopharmacology. 98:1989;93-96.
3. Ardid D., Guilbaud G. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mono-neuropathy in rats. Pain. 49:1992;279-287.
4. Besson J.M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
5. Biegon A., Samuel B. Interaction of tricyclic antidepressants with opiate receptors. Biochem. Pharmacol. 29:1980;460-461.
6. Botney M., Fields H.L. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann. Neurol. 13:1983;160-164.
7. Bromm B., Meier W., Scharein E. Imipramine reduces experimental pain. Pain. 25:1986;245-257.
8. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
9. De Felipe M.C., De Ceballos M.L., Fuentes J.A. Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin. Eur. J. Pharmacol. 125:1986;193-199.
10. 2 adenosine receptors in spinal mechanisms of antinociception. Eur. J. Pharmacol. 139:1987;215-223.
11. Eschalier A., Montastruc J.L., Devoize J.L., Rigal F., Gaillard-Plaza G., Pechardre J.C. Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. Eur. J. Pharmacol. 74:1981;1-7.
12. Esser M.J., Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur. J. Pharmacol. 399:2000;131-139.
13. Feinmann C. Pain relief by antidepressants; possible modes of action. Pain. 23:1985;1-8.
14. Frank R.G., Kashani J.H., Parker J.C., Beck N.C., Brownlee-Duffeck M., Elliott T.R., Haut A.E., Atwood C., Smith E., Kay D.R. Antidepressant analgesia in rheumatoid arthritis. J. Rheumatol. 15:1988;1632-1638.
15. Fuller R.F.W. Enhancement of monoaminergic neurotransmision by antidepressant drugs. Enna S.J., Malick J.B., Richelson E. Antidepressants: Neurochemicals, Behavioral and Clinical Perspectives. 1981;1-12 Raven Press, New York.
16. Gringras M. A clinical trial of tofranil in rheumatic pain in general practice. J. Int. Med. Res. 4:1976;41-49.
17. Hall H., Ögren S.O. Effects of antidepressant drugs on different receptors in the brain. Eur. J. Pharmacol. 70:1981;393-407.
18. Isenberg K.E., Cicero T.J. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur. J. Pharmacol. 103:1984;57-63.
19. Iwashita T., Shimizu T. Imipramine inhibits intrathecal substance P-induced behaviour and blocks spinal cord substance P receptors in mice. Brain Res. 581:1992;59-66.
20. Keil G.J., Delander G.E. Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission. Eur. J. Pharmacol. 312:1996;7-14.
21. Kvinesdal B., Molin D., Froland A., Gram L.F. Imipramine treatment of painful diabetic neuropathy. J. Am. Med. Assoc. 251:1984;1727-1730.
22. Lee Y.W., Yaksh T.L. Pharmacology of spinal adenosine receptor, which mediates the antiallodynic action of intrathecal adenosine. J. Pharmacol. Exp. Ther. 277:1996;1642-1648.
23. Leland N.H., Barry D.G. Changes of substance P-like immunoreactivity in the dorsal horn are associated with the plastic behavioral response to formalin stimulus. Brain Res. 537:1990;287-292.
24. Magni G. The use of antidepressants in the treatment of chronic pain. A review of current evidence. Drugs. 42:1991;730-748.
25. McDonald Scott W.A. The relief of pain with an antidepressant in arthritis. Practitioner. 202:1969;802-807.
26. Messing R.B., Lytle L.D. Serotonin-containing neurons: their possible role in pain and analgesia. Pain. 4:1977;1-21.
27. Olah M.E., Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 15:1995;581-606.
28. Pareek S.S., Chopde C.T., Thakurdesai P.A. Adenosine enhances analgesic effect of tricyclic antidepressants. Int. J. Pharmacol. 26:1994;159-161.
29. Phillis J.W. Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants. Br. J. Pharmacol. 83:1984;567-575.
30. Phillis J.W., Wu P.H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp. Biochem. Physiol. 72C:1982;179-187.
31. Reichenberg K., Gaillard-Plaza G., Montastruc J.L. Influence of naloxone on the nociceptive effects of some antidepressant drugs. Arch. Int. Pharmacodyn. Ther. 275:1985;78-85.
32. Roberst M.H.T. 5-Hydroxytryptamine and antinociception. Neuropharmacology. 23:1984;1529-1536.
33. Rosenblatt M.R., Reich J., Dehring D. Tricyclic antidepressants in treatment of depression and chronic pain. Anaesth. Analg. 63:1984;1025-1032.
34. Salter M.W., DeKoninck Y., Henry J.L. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog. Neurobiol. 41:1993;125-156.
35. Sattin A., Stone T.W., Taylor D.A. Biochemical and electropharmaceutical studies with tricyclic antidepressants in rat and guinea-pig cerebral cortex. Life Sci. 23:1978;2621-2626.
36. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 317:1998;1-11.
37. Sawynok J. Adenosine and pain. Phillis J.W. Adenosine and Adenine Nucleotides as Regulators of Cellular Function. 1991;CRC Press, Boca Raton, FL.
38. Sawynok J., Reid A. Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine. Pain. 50:1992;113-118.
39. Sawynok J., Reid A., Esser M.J. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain. 80:1999;45-55.
40. Sawynok J., Sweeney M.I. The role of purines in nociception. Neuroscience. 32:1989;557-562.
41. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 38:1989;347-352.
42. Sierralta F., Pinardi G., Mendez M., Miranda H.F. Interaction of opioids with antidepressant-induced antinociception. Psychopharmacology. 122:1995;374-378.
43. Stone T.W. Receptors for adenosine and adenine nucleotides. Gen. Pharmacol. 22:1991;25-31.
44. Stone T.W., Taylor D.A. Antidepressant drugs potentiate suppression by adenosine of neuronal firing in rat cerebral cortex. Neurosci. Lett. 11:1979;93-97.
45. Van Praag H.M. In search of the mode of action of antidepressants. Neuropharmacology. 22:1983;433-440.
46. Yamamoto T., Yaksh T.L. Spinal pharmacology of thermal hyperalgesia induced by incomplete ligation of sociatic nerve. Pharmacol. Biochem. Behav. 17:1991;817-826.
47. Zhao Y., Zhang C., Kang Y., Qiao J., Dafny N. Endogenous adenosine involved in the mediation of spinal antinociception produced by stimulating locus coeruleus. Life Sci. 65:1999;67-74.